Abstract-Ambulatory blood pressure (BP) monitoring provides a more precise measure of BP status than clinic BP and is currently recommended in the evaluation of high BP in children and adolescents. However, ambulatory BP monitoring may not always be available. Our aim was to determine the clinic BP percentile most likely to predict ambulatory hypertension. We evaluated clinic and ambulatory BP in 247 adolescents (median age, 15.7 years; 63% white; 54% male). Clinic BP percentile (based on the fourth report and the 2017 American Academy of Pediatrics clinical practice guidelines) and ambulatory BP status (normal versus hypertension) were determined by age-, sex-, and height-specific cut points. Sensitivity and specificity of different clinic BP percentiles and cutoffs to predict ambulatory hypertension were calculated. Forty (16%) and 67 (27%) patients had systolic hypertension based on the fourth report and the 2017 guidelines, respectively, whereas 38 (15%) had wake ambulatory systolic hypertension. The prevalence of ambulatory wake systolic hypertension increased across clinic systolic BP percentiles, from 3% when clinic systolic BP was <50th percentile to 41% when ≥95th percentile. The 2017 guidelines' 85th systolic percentile had similar sensitivity (86.8%) and better specificity (57.4% versus 48.1%) than elevated BP (≥90th percentile or ≥120 mm Hg) to diagnose ambulatory hypertension. When evaluating adolescents for hypertension, 2017 guidelines' clinic systolic 85th percentile may be the optimal threshold at which to perform ambulatory BP monitoring. (Hypertension. 2018;72:955-961.
A history of high blood pressure (BP) in children and adolescents is associated with adult hypertension 1, 2 and adverse cardiovascular outcomes. [3] [4] [5] Hypertension is diagnosed based on the presence of persistent high BP in the clinic setting, 6, 7 but the 2017 clinical practice guideline (CPG) recommends 24-hour ambulatory BP (ABP) for confirmation of hypertension. Several studies have shown relatively poor correlation between clinic and 24-hour ABP, [8] [9] [10] [11] [12] a more robust measure of BP status, which has stronger association with target organ damage in both adult 13, 14 and pediatric [15] [16] [17] [18] [19] [20] [21] populations. A study by Davis et al 9 even suggested universal ABP monitoring (ABPM) as the most economic approach for the evaluation of children and adolescents with high clinic BP.
In 2017, the American Academy of Pediatrics published a new CPG for screening and management of high BP in children and adolescents, 7 replacing the previous fourth report. 6 A significant change in the 2017 CPG is the publication of new normative pediatric BP tables based on normal weight children only (excluding children with body mass index >85% percentile); these BP values are lower than those in the fourth report. Additionally, the 2017 CPG is aligned with the 2017 American College of Cardiology/American Heart Association guidelines of high BP in adults, 22 in its adoption of singlevalue BP of 120/80 and 130/80 mm Hg for elevated BP and hypertension, respectively, in all patients ≥13 years of age.
Consistent with the literature about the advantages of ABPM, the 2017 CPG also formally recommend performance of ABPM in every patient with persistent hypertension (>3 clinic visits) or elevated BP (>1 year). However, ABPM is not readily available in all pediatric clinical practices; therefore, implementation of this recommendation may be difficult.
The SHIP AHOY (Study of Hypertension In Pediatrics, Adult Hypertension Onset in Youth Study) is a cross-sectional cohort study designed to determine BP levels and phenotypes (clinic+ABPM) that predict BP-related target organ damage in adolescents. 23 Using a sample of the first 247 participants in this cohort, with both clinic BP measured by rigorous protocol and ABP data, we sought to identify the clinic BP cut point that best predicts ambulatory hypertension. Because this is a transition period from the fourth report to the 2017 CPG, we categorized clinic BP based on both guidelines, to allow comparison between both of them in predicting ambulatory hypertension.
Methods
The data that support the findings of this study are available from the corresponding author on reasonable request. All information on the rationale and design of the SHIP AHOY study is available elsewhere. 23 Briefly, the study recruited otherwise healthy adolescents across a wide range of BP percentiles, including healthy volunteers or referred patients. Participants were eligible if they were 11 to 19 years of age without exclusion criteria (pregnant or breastfeeding females; symptomatic stage 2 hypertension; use of antihypertensive medication within the past 6 months; receiving metformin and lipid-lowering agents; or medications known to affect BP, including glucocorticoids, calcineurin inhibitors, and oral decongestants). Patients were also excluded if they had any medical condition known to be associated with the potential for elevated BP, such as diabetes; clinically significant proteinuria (verified first morning urine protein/creatinine ratio of ≥1.0); known history of chronic kidney disease or an estimated glomerular filtration rate ≤90 mL/min per 1.73 m 2 ; congestive heart failure, obstructive valvular disease, or cardiomyopathy; secondary causes of hypertension; uncorrected coarctation of the aorta; diagnosis of obstructive sleep apnea; or any other clinically significant unstable medical condition.
Participants were categorized by clinic systolic BP (SBP) as lowrisk SBP (Clinic SBP <75th percentile), mid-risk SBP (80th-<90th percentiles), or high-risk SBP (≥90th percentile), with an intention to recruit similar number of participants in each category. The study was initiated before the publication of the 2017 CPG, and BP stratification at enrollment was based on the fourth report BP tables and percentiles.
On enrollment, demographic (age, sex, race, and ethnicity) and medical history information were collected; weight and height were measured. The study protocol has undergone institutional review board review, and written informed consent/assent was obtained from all enrolled participants according to local institutional review board requirements.
Clinic BP Measurements
Clinic BP status was determined based on the average of 6 BPs obtained by auscultation over 2 visits 1 to 2 weeks apart, measured according to a standardized method consistent with the fourth report and 2017 CPG guidelines. The mid-upper arm circumference was measured, and a cuff was selected so that the length of the cuff bladder would be equal to 80% to 100% of the arm circumference. All participants had suitable cuff size for the arm circumference, with no cases of arm circumference too big (>52.0 cm) for the largest cuff. The BP was taken in the seated position in the right arm, resting at heart level, after 5 minutes of rest with an aneroid sphygmomanometer (Mabis Medic-Kit 5, Mabis Healthcare, Waukegan, IL) purchased for the sake of this study. Each site's personnel received standardized training in BP measurement. BP was measured 4× at 2-minute intervals on each of the 2 visits, discarding the first measurement on each occasion. The mean of the 6 remaining BP measurements was used in analysis.
ABP Measurement
ABP was measured with the OnTrak 90 227 device (SpaceLabs, Snoqualmie, WA), an oscillometric BP monitor that uses the same algorithm as the device that was used to generate the most commonly used pediatric normative ABPM data set. 24 Using the arm circumference measurement obtained as part of the auscultatory BP measurement, a properly sized cuff was selected and the monitor placed on the participant. Three resting BPs were obtained immediately after monitor placement to confirm correct placement and function of the monitor. For each 26-hour recording, measurements were obtained every 20 minutes through the day and night. A diary was kept by the participant to record time of sleep, time of waking, and timing of any napping. Diary data were used to divide the ABPM studies into accurate sleep-wake periods. No hours of monitoring were discarded, consistent with current American Heart Association recommendations for pediatric ABPM.
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BP Status Classification
Clinic BP was initially classified according to the fourth report on BP in children 6 : (1) • Normal BP: BP <90th percentile for age, sex, and height; or <120/<80 mm Hg for adolescents ≥13 years old.
• Elevated BP: BP reading ≥90th percentile and <95th percentile for age, sex, and height; or 120 to 129/<80 mm Hg for adolescents ≥13 years old.
• Hypertension: BP >95th percentile for age, sex, and height; or ≥130/80 mm Hg for adolescents ≥13 years old. Additional classification divided the cohort based on a universal cut off of SBP ≥120 or DBP ≥80 across the entire age range.
ABPM was analyzed based on the American Heart Association recommendations for pediatric ABPM, 25 using pediatric normative ABPM data obtained with the same device 24 : (1) normal ABP: mean 24-hour SBP/DBP and both wake and sleep BP <95th percentile for sex and height and (2) ambulatory hypertension: mean 24-hour SBP/ DBP or wake/sleep BP ≥95th percentile for sex and height. ABP index was calculated as the mean measured BP divided by the 95th percentile for sex and height, meaning that patients with normal ABP had ABP index <1, whereas ambulatory hypertension was define as ABP index of ≥1.
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Statistical Analysis
For descriptive statistics, categorical variables are presented as percentages, and continuous variables are presented as mean±SD or median (interquartile range) depending on their distribution. McNemar's test was used for comparison between prevalence of the various clinic BP strata, and Student t test and Wilcoxon signed-rank test were used to compare different BP percentiles and indices of the study sample. Clinic SBP was stratified in the following groups: <50th, 50-79th, 80-89th, 90-94th, and ≥95th percentiles. Sensitivities and specificities for diagnosis of ambulatory hypertension were calculated for BP percentiles ≥80 (in 5 percentile increments), as well as for elevated BP (2017 CPG), 120/80 as universal cutoffs across the entire age range, and prehypertension (fourth report). We also compared the sensitivities and specificities of different cutoffs to diagnose wake systolic hypertension based on only 3 readings (from the visit just before ABPM placement). Of the tables detailing the 2017 CPG clinic SBP, percentiles by age and height percentiles were generated based on the program published at https:// sites.google.com/a/channing.harvard.edu/bernardrosner/pediatricblood-press/childhood-blood-pressure. All statistical analyses were performed using SAS 9.3 statistical software (SAS Institute Inc, Cary, NC).
Results
Study Population
Participant characteristics are presented in Table 1 . Median age was 15.7 years, 55% were male, 63% white, and 16%
Hispanic. The sample cohort was relatively overweight, with median body mass index of 25.8 kg/m 2 and median body mass index percentile of 91.
Clinic BP Status
Our study population was relatively hypertensive, with a median BP of 121/81, reflecting the intension to recruit similar number of participants to each risk group. Fifty-one percent of the study population were stratified in the low-risk BP group, 20% in the mid-risk group, and 29% in the highrisk BP group. Clinic BP status is summarized in Table 2 . Median BP percentiles and the prevalence of both systolic and diastolic hypertension were significantly higher when BP was categorized based on the 2017 CPG. For example, 27% of participants were classified as having systolic hypertension using the 2017 CPG, while only 16% had systolic hypertension by the fourth report (P<0.001). The median DBP percentiles were significantly higher than the median SBP percentiles, regardless of which guideline was used. Accordingly, the prevalence of diastolic hypertension was significantly higher than for systolic hypertension. The prevalence of hypertension defined as either SBP or DBP hypertension was 43% based on the fourth report compared with 61% based on the 2017 CPG (P<0.001).
Ambulatory Hypertension Status
ABP status is presented in Table 3 . The ABPM studies obtained were 26 hours (interquartile range, 25.6-26.6) in duration and contained 72 readings (interquartile range, 65-77) per study with a success rate of 86% (interquartile range, 76% to 92%). Median wake BP was 122/71 mm Hg, and median sleep BP was 107/56 mm Hg. As opposed to the clinic BP, ambulatory SBP index was significantly higher than ambulatory DBP index (P<0.001 for both wake and sleep hours). Fifteen percent had wake systolic hypertension, and 13% had wake diastolic hypertension. During sleep time, 17% had systolic hypertension and 12% had diastolic hypertension. Taking into account SBP/DBP and wake/sleep ABP, 71 (29%) participants had ambulatory hypertension.
Systolic ABP Status Based on Clinic BP
Prevalence of wake, sleep, and overall (wake or sleep) systolic ambulatory hypertension by different clinic SBP percentile categories is presented in Figure 1A through 1C, respectively. Prevalence of ambulatory hypertension increased across clinic SBP percentiles, from 3% when SBP percentile was <50% to 41% when SBP percentile was ≥95 in the case of wake systolic hypertension, and from 4% when SBP percentile was <50% to 53% when SBP percentile was ≥95, for overall (wake or sleep) systolic hypertension. When using the 2017 CPG percentiles, fewer patients with clinic SBP percentiles <95 had ambulatory hypertension. Even though the 2017 was less likely to miss ambulatory hypertension with a clinic SBP <95th percentile, there was still a high prevalence of white-coat hypertension (high in clinic and normal on ABP), such that whatever guidelines were used, ≈60% of subjects with clinic BP >95th percentile had normal ABP. Sensitivities and specificities of different clinic BP cut points to predict ambulatory hypertension are presented in Table 4 and Table S1 in the online-only Data Supplement. Both elevated SBP (based on the 2017 CPG) and a universal cutoff of SBP ≥120 had sensitivity 86.8% but specificity of only 47.9 and 49.2%, respectively, to predict wake ambulatory hypertension. Sensitivity decreased and specificity increased with higher BP percentiles. The 2017 CPG 85th percentile cutoff was the only cutoff with both similar sensitivity (86.8%) and higher specificity (57.4%) than elevated SBP level or SBP ≥120. Overall, the fourth report's percentiles as cutoffs had lower sensitivities and higher specificities than their equivalent CPG percentiles (Table S1 ).
When clinic BP was defined based on the 3 readings obtained on the visit just before ABPM placement, sensitivities to diagnose wake systolic hypertension were 81.6% for elevated SBP and 120 mm Hg and 84.2% for the CPG 85th percentile, lower than when all 6 study readings were used, but with less effect on the CPG 85th percentile. Specificities, however, of all 3 cutoffs were slightly higher, 50.2%, 50.7%, and 59.8%, for elevated SBP, 120 mm Hg, and the CPG 85 th percentile, respectively.
Data for nocturnal and overall (wake or sleep) systolic hypertension (Tabe S1) showed that the 2017 CPG BP level at the 85th percentile had slightly lower sensitivity (82.5% versus 87.5% in the case of nocturnal hypertension and 80.4% versus 83.9% in the case of overall hypertension) but higher specificity (56.7% versus 47.8% in the case of nocturnal hypertension and 59.0% versus 49.5% in the case of overall hypertension) to diagnose ambulatory hypertension than elevated BP.
Diastolic BP Status Based on Clinic BP
Prevalence of wake, sleep, and overall (wake or sleep) diastolic ambulatory hypertension in different DBP percentile categories is presented in Figure 2A through 2C, respectively. No ambulatory hypertension was observed in patients with clinic DBP percentile <50; only 23% and 32% of participants with clinic DBP percentile >95th (2017 CPG) had wake and overall diastolic ambulatory hypertension, respectively. Sensitivity and specificity of different DBP percentiles and prehypertension/elevated BP and ambulatory diastolic hypertension are presented in Table S2 . Both prehypertension (fourth report) and elevated BP (2017 CPG) had sensitivity of 87% and of specificity ≈50% to diagnose wake ambulatory diastolic hypertension. There was no specific clinic DBP percentile with clear advantage than prehypertension/elevated BP to predict ambulatory diastolic hypertension. As in the case of SBP, using DBP of 80 mm Hg as a universal cutoff across the entire age range yielded similar sensitivity as the elevated DBP cutoff with slightly better specificity.
Discussion
In this study of a large adolescent cohort, we show that the 2017 CPG BP percentiles have superior sensitivity compared with those of the fourth report in predicting ambulatory hypertension and that the 2017 CPG 85th SBP percentile may serve as the best threshold to perform ABPM.
We also found a discordance between clinic and ABP, which confirms the findings of previous retrospective pediatric studies. [9] [10] [11] [12] In 2 of these studies, conducted on otherwise healthy patients referred for evaluation of hypertension, 12% to 17% of those with normal clinic BP/prehypertension had ambulatory hypertension (masked hypertension), whereas 46% to 55% of those with clinic hypertension had normal ABP (white-coat hypertension). 9, 10 In another study, conducted on a mixed population (including patients already treated for hypertension and chronic kidney disease or diabetes mellitus patients), 36% patients of nonhypertensive per clinic BP had masked hypertension, whereas 36% of hypertensives actually had white-coat hypertension.
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Consistent with these studies, our findings underscore the importance of ABPM, both in confirming the diagnosis and in minimizing underdiagnosis of hypertension. However, because applying ABPM on all patients with suspected hypertension may be unrealistic, we tried to identify a clinic BP cut point that would optimize the utility of ABPM. We, therefore, looked at different BP percentiles, as well as the recently defined elevated BP cutoff and a universal cutoff of 120/80 as predictors of ambulatory hypertension.
We demonstrated that the 2017 CPG 85th SBP percentile provided the best sensitivity/specificity combination to predict ambulatory hypertension, with potentially higher specificity and similar or slightly lower sensitivity than the clinic BP category elevated BP (called prehypertension in the fourth report) and 120 mm Hg. Interestingly, when clinic BP was defined based on readings from 1 visit only, the sensitivity of the CPG 85th percentile was higher than that of the other 2 cutoffs, further supporting the use of this cutoff if decision about ABPM is based on the findings of 1 clinic visit. Our data extend the observations of previous studies to examine at what level of clinic BP is ambulatory hypertension (and thus risk of target organ damage) likely to occur. In our cohort, 16/38 (42%) patients of participants with wake systolic ambulatory hypertension did not have clinic hypertension (according to the 2017 CPG), and 11 of those (29% of wake systolic hypertensives) had SBP ≥85th percentile, therefore, using the CPG 85th percentile as the cut point to obtain an ABPM, similarly to using elevated BP, would identify ≈70% of patients with masked hypertension.
However, the systolic BP definition of elevated BP over the age of 13 years (≥120 mm Hg) is in many cases, especially in older male teenagers, lower than the 85th SBP percentile. In our study, 49.4% of participants had SBP ≥85th percentile, compared with 57.5% who were above 120 mm Hg (P<0.001). Hence, fewer patients would require an ABPM if the 85th percentile would be used to suspect ambulatory hypertension. Therefore, in cases of limited availability of ABPM, the CPG 85th percentile could be a more appropriate SBP level in an adolescent for ABPM referral. For practical purposes, since the 2017 CPG guidelines detail only the 50th, 90th, and 95th percentiles, we include 2 tables (Tables S3 and S4 ) detailing the SBP 85th percentile by age and height percentile for both boys and girls aged 5 to 17 years.
As BP levels >120/80 are associated with adverse outcomes in adults, 22, 27, 28 we performed additional analysis applying this cutoff for all participants, including 11-to 13-years-old children. In this age range, elevated BP is defined as BP ≥90th percentile, which in contrast to older adolescents is generally <120/80. Using this threshold yielded similar sensitivity and slightly better specificity than the elevated BP cutoff (but still lower than that of the 85th percentile). The number of 11-to 13-year-olds in our study was small (18 participants), but this might suggest that in this age range, BP ≥120/80 may be an appropriate cut off to perform ABPM.
Our results also showed that the 2017 CPG BP values have a consistently higher sensitivity for ambulatory hypertension detection, compared with the fourth report percentiles. This is not surprising because as opposed to the fourth report, the CPG percentiles are based on subjects with normal weight status only, while the fourth report included youth with obesity, a known risk factor for BP elevation. Therefore, in most cases, a patient with a specific BP percentile according to the fourth report has a higher BP percentile according to the 2017 CPG, as demonstrated by the higher BP percentiles of our population based on the 2017 CPG, compared with the fourth report (median SBP of 84 versus 80; median DBP of 93 versus 90). One limitation of our study is that we oversampled participants with higher BP levels, and participants were relatively overweight or obese. This is representative of the typical pediatric patients referred for hypertension evaluation and do not represent a general childhood population. In addition, although the clinic BP guidelines were revised to include a single numeric hypertension definition of ≥130/80 mm Hg in all patients ≥13 years old, the ABP guidelines have not been revised and still use specific height and sex percentiles cutoffs. It is, therefore, challenging to define phenotypes of ambulatory hypertension according to the new CPG guidelines, and we were limited to focusing on associations between BP percentiles and ambulatory hypertension. Moreover, although ABPM is a more robust measure of BP, 29 it might have limited reproducibility too. 30 Another limitation is that clinic BP was measured by auscultation, whereas ABP is assessed by oscillometry, methods which are not perfectly correlated. It is also unclear how our determination of clinic BP (average of 6 measurements obtained over 2 visits) is applicable to clinical settings, in which readings in 3 consecutive occasions are required to diagnose hypertension. 7 
Perspectives
Evaluating BP using the 2017 CPG may provide superior prediction of ambulatory hypertension than categorizing clinic BP with fourth report. Use of the CPG 85th systolic percentile generates the best sensitivity and specificity in prediction of ambulatory hypertension. When evaluating adolescents referred to clinic for suspected hypertension, especially in case of limited ABPM availability, CPG SBP percentile of ≥85 may be the optimal threshold to perform an ABPM. Additional research is needed to determine if referral for ABPM at the 85th percentile leads to changes in hypertension therapy and ultimate reduction in BP-related target organ damage.
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